Norrie Disease (Pseudoglioma) (NDP) (N-Term) Peptide
NDP
Reactivity: Human
BP
Sodium azide
-
- Target See all Norrie Disease (Pseudoglioma) (NDP) products
- Norrie Disease (Pseudoglioma) (NDP)
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
18 amino acids near the amino terminus of human Norrin.
Human
-
-
- Application Notes
- Norrin peptide is used for blocking the activity of Norrin.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- Norrie Disease (Pseudoglioma) (NDP)
- Synonyms
- EVR2 Peptide, FEVR Peptide, ND Peptide, evr2 Peptide, fevr Peptide, xnorrin Peptide, Ndph Peptide, RGD1563968 Peptide, NDP, norrin cystine knot growth factor Peptide, Norrie disease (pseudoglioma) L homeolog Peptide, Norrie disease (pseudoglioma) (human) Peptide, NDP Peptide, ndp.L Peptide, Ndp Peptide
-
You are here:
